cbdMD, Inc.
YCBDNYSECIK 1644903Consumer staplesFiscal year ends Sep 30
Reports and events: 272 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-0118:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006177 |
| 2024-02-1618:42 ET | S-1 | Registration statement | 0001437749-24-004416 |
| 2024-02-1416:07 ET | DEF 14A | Proxy statementPeriod 2024-03-29 | 0001437749-24-004151 |
| 2024-02-1316:06 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001437749-24-003902 |
| 2024-02-0216:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-002975 |
| 2024-01-2918:22 ET | 10-K/A | Annual report, amendedPeriod 2023-09-30 | 0001437749-24-002340 |
| 2023-12-2216:01 ET | 10-K | Annual reportPeriod 2023-09-30 | 0001437749-23-035228 |
| 2023-10-2618:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-028992 |
| 2023-09-2516:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-026701 |
| 2023-08-2208:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-024369 |
| 2023-08-1116:30 ET | DEF 14A | Proxy statementPeriod 2023-09-22 | 0001437749-23-023343 |
| 2023-08-1017:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-023130 |
| 2023-07-2116:02 ET | 8-K | 8.01 Other events | 0001437749-23-020439 |
| 2023-06-2618:23 ET | 8-K | 8.01 Other events | 0001437749-23-018313 |
| 2023-05-2416:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-015713 |
| 2023-05-1916:02 ET | 8-K | 8.01 Other events | 0001437749-23-015284 |
| 2023-05-1516:26 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-014599 |
| 2023-05-0317:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-012366 |
| 2023-05-0318:05 ET | 10-K/A | Annual report, amendedPeriod 2022-09-30 | 0001437749-23-012159 |
| 2023-04-2706:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-011231 |
| 2023-04-1917:17 ET | 8-K | 8.01 Other events | 0001437749-23-010657 |
| 2023-04-1416:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-010326 |
| 2023-03-1716:02 ET | 8-K | 8.01 Other events | 0001437749-23-007052 |
| 2023-03-1316:54 ET | S-1 | Registration statement | 0001437749-23-006378 |
| 2023-03-0217:12 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-23-005246 |
| 2023-02-2216:53 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001437749-23-004179 |
| 2023-02-2219:06 ET | 8-K | 8.01 Other events | 0001437749-23-004026 |
| 2023-02-1316:06 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001437749-23-003144 |
| 2023-02-0717:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-23-002717 |
| 2023-01-2316:55 ET | 8-K | 8.01 Other events | 0001437749-23-001606 |
| 2023-01-0409:06 ET | DEF 14A | Proxy statementPeriod 2023-02-16 | 0001437749-23-000224 |
| 2022-12-2016:02 ET | 10-K/A | Annual report, amendedPeriod 2022-09-30 | 0001437749-22-029447 |
| 2022-12-1616:19 ET | 8-K | 8.01 Other events | 0001437749-22-029263 |
| 2022-12-1516:05 ET | 10-K | Annual reportPeriod 2022-09-30 | 0001437749-22-029136 |
| 2022-11-1616:02 ET | 8-K | 8.01 Other events | 0001437749-22-027536 |
| 2022-10-2016:02 ET | 8-K | 8.01 Other events | 0001437749-22-024461 |
| 2022-10-0419:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-22-023510 |
| 2022-09-1916:02 ET | 8-K | 8.01 Other events | 0001437749-22-022697 |
| 2022-08-1716:01 ET | 8-K | 8.01 Other events | 0001437749-22-020817 |
| 2022-08-1216:02 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-22-020339 |
| 2022-08-1116:21 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001437749-22-020140 |
| 2022-07-1816:06 ET | 8-K | 8.01 Other events | 0001654954-22-009789 |
| 2022-06-2317:12 ET | 8-K | 1.01 Entry into a material agreement | 0001654954-22-008692 |
| 2022-06-2107:52 ET | SC 13D/A | Ownership report, active investor, amended | 0001654954-22-008534 |
| 2022-06-1716:08 ET | 8-K | 8.01 Other events | 0001654954-22-008490 |
| 2022-06-1407:17 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-22-008290 |
| 2022-06-1316:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-008274 |
| 2022-06-0316:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-22-007923 |
| 2022-06-0116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-22-007804 |
| 2022-05-1916:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001654954-22-007213 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 20:31 ET. Listed shows no prices and gives no investment advice.